ArticleScientific reports2026
Disruption of zinc homeostasis reduces histone acetylation levels in normal and tumor cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Zinc homeostasis plays a critical role in cellular function, yet its dysregulation may lead to cytotoxicity. Based on the unexpected finding that excessive zinc downregulates the transcription of cardiac-related factors in mouse cardiomyocytes, this study reveals a mechanistic pathway wherein cytoplasmic zinc overload reduces histone acetyltransferase activity, subsequently lowering histone acetylation and ultimately decreasing the transcriptional levels of target genes. The universality of this mechanism was further confirmed across multiple cell types. By investigating the phenomenon of zinc-induced autophagy regulated by acetylation, we explored the potential therapeutic implications of zinc as a drug. Through comparative analysis of cells with varying sensitivity to zinc, we identified aberrant expression of zinc transporters under physiological conditions as a primary factor contributing to zinc-induced toxicity. This finding suggests that zinc transporters may serve as potential therapeutic targets. This study is the first to elucidate the molecular link between zinc homeostasis and histone acetylation, providing a novel perspective for understanding zinc metabolism-related diseases and zinc-targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.